Ampio Pharmaceuticals Stock Price

0.049 (2.85%)
Upgrade to Real-Time
Regular Market


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Ampio Pharmaceuticals Inc AMPE AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
0.049 2.85% 1.769 10:15:34
Open Price Low Price High Price Close Price Prev Close
1.70 1.68 1.78 1.72
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
889 214,345 $ 1.72 $ 368,916 9,258,357 0.4535 - 2.98
Last Trade Time Type Quantity Stock Price Currency
10:17:03 25 $ 1.7699 USD

Ampio Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 327.36M 185.06M 182.52M $ - $ - -0.14 -15.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Ampio Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AMPE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.561.791.441.611,209,3680.20913.4%
1 Month1.621.901.441.681,216,3000.1499.2%
3 Months1.562.591.251.922,864,3320.20913.4%
6 Months0.82052.980.72081.774,463,0320.9485115.6%
1 Year0.492.980.45351.363,752,5961.28261.02%
3 Years3.223.2350.261.122,052,524-1.45-45.06%
5 Years4.114.94990.261.251,517,685-2.34-56.96%

Ampio Pharmaceuticals Description

Ampio Pharmaceuticals Inc is a biopharmaceutical company. The company focused primarily on developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process and decreasing vascular permeability. Ampio's leading product candidates are Ampion and Optina. It is currently conducting the second pivotal clinical trial in the United States for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee.

Your Recent History
Ampio Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.